Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
7152 | 1323 | 42.5 | 93% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
222 | 19941 | LYMPHANGIOGENESIS//ANGIOGENESIS//ENDOSTATIN |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ANGIOPOIETIN 2 | Author keyword | 139 | 59% | 12% | 156 |
2 | TIE2 | Author keyword | 94 | 57% | 8% | 112 |
3 | ANGIOPOIETIN | Author keyword | 93 | 44% | 12% | 163 |
4 | ANGIOPOIETIN 1 | Author keyword | 83 | 48% | 10% | 126 |
5 | ANGIOPOIETINS | Author keyword | 61 | 51% | 7% | 86 |
6 | COMP ANG1 | Author keyword | 38 | 93% | 1% | 14 |
7 | TIE 2 | Author keyword | 37 | 47% | 4% | 59 |
8 | TIE2 RECEPTOR | Author keyword | 25 | 75% | 1% | 18 |
9 | TIE1 | Author keyword | 23 | 74% | 1% | 17 |
10 | TIE 2 RECEPTOR | Author keyword | 17 | 75% | 1% | 12 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ANGIOPOIETIN 2 | 139 | 59% | 12% | 156 | Search ANGIOPOIETIN+2 | Search ANGIOPOIETIN+2 |
2 | TIE2 | 94 | 57% | 8% | 112 | Search TIE2 | Search TIE2 |
3 | ANGIOPOIETIN | 93 | 44% | 12% | 163 | Search ANGIOPOIETIN | Search ANGIOPOIETIN |
4 | ANGIOPOIETIN 1 | 83 | 48% | 10% | 126 | Search ANGIOPOIETIN+1 | Search ANGIOPOIETIN+1 |
5 | ANGIOPOIETINS | 61 | 51% | 7% | 86 | Search ANGIOPOIETINS | Search ANGIOPOIETINS |
6 | COMP ANG1 | 38 | 93% | 1% | 14 | Search COMP+ANG1 | Search COMP+ANG1 |
7 | TIE 2 | 37 | 47% | 4% | 59 | Search TIE+2 | Search TIE+2 |
8 | TIE2 RECEPTOR | 25 | 75% | 1% | 18 | Search TIE2+RECEPTOR | Search TIE2+RECEPTOR |
9 | TIE1 | 23 | 74% | 1% | 17 | Search TIE1 | Search TIE1 |
10 | TIE 2 RECEPTOR | 17 | 75% | 1% | 12 | Search TIE+2+RECEPTOR | Search TIE+2+RECEPTOR |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TIE2 RECEPTOR | 254 | 55% | 24% | 315 |
2 | TIE2 | 90 | 55% | 9% | 113 |
3 | TIE 2 LIGAND ANGIOPOIETIN 2 | 76 | 78% | 4% | 50 |
4 | OVEREXPRESSING ANGIOPOIETIN 1 | 74 | 59% | 6% | 82 |
5 | RECEPTOR TIE 2 | 56 | 89% | 2% | 25 |
6 | PLASMA ANGIOPOIETIN 1 | 44 | 81% | 2% | 26 |
7 | SOLUBLE TIE | 38 | 93% | 1% | 14 |
8 | TEK | 36 | 61% | 3% | 38 |
9 | DESIGNED ANGIOPOIETIN 1 VARIANT | 35 | 89% | 1% | 16 |
10 | ANGIOPOIETIN 1 | 31 | 23% | 9% | 117 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system | 2009 | 359 | 144 | 81% |
Angiopoietins in angiogenesis | 2013 | 53 | 120 | 78% |
Angiopoietin-2: An Attractive Target for Improved Antiangiogenic Tumor Therapy | 2013 | 41 | 44 | 77% |
Angiopoietin signaling in the vasculature | 2013 | 34 | 88 | 86% |
Targeting the ANGPT-TIE2 pathway in malignancy | 2010 | 127 | 144 | 69% |
The role of the Angiopoietins in vascular morphogenesis | 2009 | 125 | 151 | 83% |
Angiopoietins: a link between angiogenesis and inflammation | 2006 | 246 | 82 | 65% |
Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling | 2006 | 161 | 134 | 89% |
Signaling and functions of angiopoietin-1 in vascular protection | 2006 | 139 | 107 | 86% |
Orchestral actions of angiopoietin-1 in vascular regeneration | 2013 | 21 | 63 | 65% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GEN INTERNAL MED NEPHROL RHEUMATOL | 6 | 41% | 0.9% | 12 |
2 | CREAT INITIAT CARDIAC REGENERAT | 6 | 50% | 0.7% | 9 |
3 | MED MANNHEIM CBTM | 4 | 36% | 0.7% | 9 |
4 | S113 | 3 | 100% | 0.2% | 3 |
5 | ANGIOGENESIS TUMOR TARGETING UNIT | 3 | 33% | 0.6% | 8 |
6 | HDRCRP | 3 | 60% | 0.2% | 3 |
7 | RKCSB | 3 | 19% | 1.0% | 13 |
8 | CREAT INITIAT ENDOTHELIAL CELLS | 3 | 35% | 0.5% | 6 |
9 | CLIN IMMUNOL BIOL SAMPLE MANAGEMENT | 2 | 67% | 0.2% | 2 |
10 | HCCLB | 2 | 67% | 0.2% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000094018 | FLT 1//VEGF RECEPTORS//VEGF165B |
2 | 0.0000093371 | ANGIOPOIETIN LIKE PROTEIN 2//ANGIOPOIETIN LIKE PROTEIN 3//BETATROPHIN |
3 | 0.0000087799 | ENDOCAN//ESM 1//ENDOTHELIAL CELL SPECIFIC MOLECULE 1 |
4 | 0.0000086694 | PERICYTES//PERICYTE//BOVINE RETINAL PERICYTES |
5 | 0.0000080478 | ADAPHOSTIN//BONE MARROW MICROVESSEL DENSITY//PEDIAT PEDIAT ONCOL HEMATOL |
6 | 0.0000079738 | BRAIN VASCULARITY//NEUROVASCULAR NICHE//BRAIN CAPILLARY DENSITY |
7 | 0.0000076423 | VASOHIBIN 1//VASOHIBIN//VASOHIBIN 2 |
8 | 0.0000073905 | DELTA LIKE LIGAND 4//DLL4//ARTERIAL VENOUS DIFFERENTIATION |
9 | 0.0000062229 | ARTERIOGENESIS//THERAPEUTIC ANGIOGENESIS//GRP EXPT CLIN ARTERIOGENESIS |
10 | 0.0000053795 | PLASMA VEGF//MANCHESTER RENAL GRP//PLASMA VASCULAR ENDOTHELIAL GROWTH FACTOR |